{"meta":{"page":1,"per_page":50,"max_per_page":100,"total":16,"total_is_capped":false,"direct_labels_cover":0,"predictions_cover":16,"direct_label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline (scores rank; they never assert a category)","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12","author_layer_release":"2026-06-26"},"query_hash":"6b4bed8a19df","filters":{"venue":"Biotechnology Law Report"}},"results":[{"id":"W2974520714","doi":"10.1089/blr.2019.29135.rbk","title":"Disharmonization in the Regulation of Transgenic Plants in Europe","year":2019,"lang":"en","type":"article","venue":"Biotechnology Law Report","topic":"Genetically Modified Organisms Research","field":"Agricultural and Biological Sciences","cited_by":9,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Conestoga College","funders":"","keywords":"Parliament; European union; Member state; Legislation; Political science; Legislature; Member states; European commission; State (computer science); Genetically modified organism; Commission; Law; Public administration; Biotechnology; Business; International trade; Biology; Politics","authors":[{"name":"Ramesh Bikram Karky","is_ca":true},{"name":"Mark Perry","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.02205585330586195,"gpt":0.2312997247597048,"spread":0.2092438714538429,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003855727,0.00005439318,0.00009932589,0.00002258486,0.00001919998,0.00000727926,0.000253408,0.0001907978,0.0001303573],"category_scores_gemma":[0.00005789886,0.00001992807,0.00001603083,0.0006241972,0.00008568434,0.00003732968,0.00003662953,0.0001449099,0.0000260093],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00001079818,"about_ca_system_score_gemma":0.000008504473,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0003131347,"about_ca_topic_score_gemma":0.001207753,"domain_scores_codex":[0.9991739,0.00006498986,0.0002469173,0.000197302,0.0001676945,0.0001492004],"domain_scores_gemma":[0.9997381,0.00004957843,0.00005877904,0.0001120742,0.00003129711,0.00001016919],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","study_design_scores_codex":[0.00001129013,0.00005316115,0.02794926,0.000003695933,0.000001499871,0.00001878689,0.00002886828,0.00001147428,0.9594485,0.00870374,0.00000762093,0.003762099],"study_design_scores_gemma":[0.00009430405,0.0000986959,0.8323629,0.000008195826,9.102764e-7,0.00005120094,0.00006215147,0.00004371798,0.1623358,0.0009951923,0.003894375,0.00005252563],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9951351,0.00002825499,0.000005459233,0.002941706,0.00002524398,0.0002784392,0.000003515405,0.00002084637,0.001561397],"genre_scores_gemma":[0.9997702,0.00003270791,0.00003477067,0.00003425115,0.000008074968,0.000005818271,0.00003136542,6.734049e-7,0.00008212282],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.8044137,"threshold_uncertainty_score":0.1471608,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2608488164","doi":"10.1089/blr.2016.29030.mk","title":"A Decade of Data Protection for Innovative Drugs in Canada: Issues, Limitations, and Time for a Reassessment","year":2016,"lang":"en","type":"article","venue":"Biotechnology Law Report","topic":"Biomedical Ethics and Regulation","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"CARE Canada","funders":"","keywords":"Intellectual property; Scope (computer science); Investment (military); Data Protection Act 1998; Treaty; Promotion (chess); Business; Welfare; Investment protection; International trade; Political science; International investment; Law; Foreign direct investment","authors":[{"name":"Megan Kendall","is_ca":true},{"name":"Declan Hamill","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.06956880997068911,"gpt":0.3430112295530542,"spread":0.2734424195823651,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005306055,0.00006233843,0.0001927434,0.00009443332,0.00002992231,0.000001430209,0.0000592887,0.0003019379,0.000002065922],"category_scores_gemma":[0.0004587501,0.00004113093,0.00001016769,0.0002084267,0.0003343517,0.00004580597,0.00005383398,0.00008971871,1.209878e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001676295,"about_ca_system_score_gemma":0.001047207,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.09213857,"about_ca_topic_score_gemma":0.1282276,"domain_scores_codex":[0.9991556,0.000009244696,0.0003479219,0.0002567916,0.0001198041,0.0001106685],"domain_scores_gemma":[0.9991735,0.00008825651,0.0001899393,0.0003193897,0.000203251,0.00002565758],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0003882986,0.0001623936,0.001172449,0.0003664168,0.0001642726,0.00003281288,0.0000701388,8.31868e-8,0.1846289,0.2481641,0.001954699,0.5628954],"study_design_scores_gemma":[0.00642853,0.001303562,0.04106424,0.0009467605,0.0001523142,0.0006396692,0.0003561838,0.001998037,0.1918958,0.04290707,0.711943,0.0003648077],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"commentary","genre_gemma":"empirical","genre_scores_codex":[0.3215187,0.000636686,0.05559668,0.6147886,0.0002385701,0.006265608,0.000405851,0.0001232897,0.0004259829],"genre_scores_gemma":[0.9854277,0.00006620789,0.01379473,0.0001023313,0.0000271599,0.0001548078,0.0001582721,0.000008932746,0.0002598876],"genre_candidate":"empirical","genre_consensus":null,"teacher_disagreement_score":0.7099883,"threshold_uncertainty_score":0.9139069,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W1967718889","doi":"10.1089/blr.2004.23.556","title":"Patenting of \"Higher Life Forms\" in Canada","year":2004,"lang":"en","type":"article","venue":"Biotechnology Law Report","topic":"Genetically Modified Organisms Research","field":"Agricultural and Biological Sciences","cited_by":4,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"","funders":"","keywords":"Download; European union; Political science; Library science; Law; Biology; Business; International trade","authors":[{"name":"Adrian Zahl","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.02110794340125666,"gpt":0.2190713244917879,"spread":0.1979633810905313,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001512094,0.00008111451,0.0001644752,0.00001375245,0.00004694708,0.000005706177,0.0002484587,0.0002058116,0.0001218081],"category_scores_gemma":[0.00009053182,0.00003353567,0.00002863136,0.0003327185,0.0001249746,0.00002442107,0.0001402776,0.0001822438,0.000006021554],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001301152,"about_ca_system_score_gemma":0.0002055539,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.8892201,"about_ca_topic_score_gemma":0.9575476,"domain_scores_codex":[0.9988787,0.00001142108,0.0003335264,0.0002420556,0.0002188575,0.0003154491],"domain_scores_gemma":[0.9996724,0.0000246388,0.00009170414,0.0001054645,0.00004217595,0.00006360834],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","study_design_scores_codex":[0.000008688281,0.00006402286,0.05098343,0.000008009074,0.00001158553,0.0006380869,0.000004504927,0.00002568628,0.9091129,0.03337332,0.00003192414,0.005737833],"study_design_scores_gemma":[0.0001891194,0.0001035939,0.5248843,0.00001516454,0.000003118282,0.0001115098,0.0000935693,0.000002176485,0.4597019,0.004421208,0.01031987,0.000154467],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9923899,0.00007045636,0.000003110211,0.005264068,0.00005887385,0.0001184487,0.000004079673,0.00003550689,0.002055597],"genre_scores_gemma":[0.9995611,0.00001169913,0.0002111242,0.0001291899,0.00001611753,0.000006865397,0.000007975949,8.85059e-7,0.00005503635],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.4739009,"threshold_uncertainty_score":0.1587407,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4251060970","doi":"10.1089/0730031041724837","title":"Schmeiser <i>v.</i> Monsanto Canada Inc.,","year":2004,"lang":"en","type":"article","venue":"Biotechnology Law Report","topic":"Intellectual Property and Patents","field":"Business, Management and Accounting","cited_by":4,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"","funders":"","keywords":"Download; Statutory law; Law; Statutory interpretation; Political science; Computer science; World Wide Web","authors":[],"retraction":null,"screen_n_in":null,"score":{"opus":0.04458843433448383,"gpt":0.19539434234246,"spread":0.1508059080079762,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001551084,0.0001752201,0.000188283,0.0001003005,0.000272841,0.00005787226,0.0003032433,0.0002874765,0.0001844536],"category_scores_gemma":[0.0001270734,0.0001467462,0.0000409988,0.0003391548,0.0001703952,0.0002867931,0.000213275,0.0002875385,0.0004443676],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0000978292,"about_ca_system_score_gemma":0.0001770997,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.7984637,"about_ca_topic_score_gemma":0.599483,"domain_scores_codex":[0.9987688,0.000002568439,0.0003150624,0.00034305,0.000215911,0.0003545946],"domain_scores_gemma":[0.9992727,0.000006537114,0.0001578927,0.0004394561,0.0001113172,0.00001210704],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0001195593,0.000314928,0.004915545,0.0001735231,0.0001986467,0.01088383,0.0000215092,0.0003401364,0.01418762,0.8866346,0.07746219,0.004747926],"study_design_scores_gemma":[0.0003085111,0.000009635603,0.0001628115,0.00002349578,0.00002150651,0.0002791516,0.00002884484,0.00003820217,0.01667316,0.004987162,0.9772169,0.0002506051],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.7270826,0.0002165244,0.000425247,0.01942103,0.001975002,0.0004368324,0.000004248873,0.0009317134,0.2495068],"genre_scores_gemma":[0.9908327,0.000007406387,0.0001501367,0.007751908,0.0002737661,0.00001414451,0.00003504349,0.00002345667,0.0009113844],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.8997547,"threshold_uncertainty_score":0.5984136,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4243854610","doi":"10.1089/blr.2012.9659","title":"Canada May Not Approve Generic Versions of OxyContin","year":2012,"lang":"en","type":"article","venue":"Biotechnology Law Report","topic":"Intellectual Property and Patents","field":"Business, Management and Accounting","cited_by":0,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"","funders":"","keywords":"Download; Volume (thermodynamics); Political science; Library science; Computer science; World Wide Web; Physics","authors":[],"retraction":null,"screen_n_in":null,"score":{"opus":0.08033790925893307,"gpt":0.20725504633266,"spread":0.1269171370737269,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002248906,0.0001247431,0.0001933442,0.0000943989,0.0001274588,0.00001222955,0.0002171481,0.0002285646,0.0002345012],"category_scores_gemma":[0.0001686415,0.0001029637,0.00005060378,0.0002751436,0.000143171,0.0002185569,0.0002030268,0.0001673095,0.0001031834],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00003791547,"about_ca_system_score_gemma":0.00007501533,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.5198594,"about_ca_topic_score_gemma":0.07940412,"domain_scores_codex":[0.9990148,0.000004640012,0.0003001203,0.0001843023,0.0001659411,0.0003301756],"domain_scores_gemma":[0.9992961,0.00001455518,0.0002444938,0.0003489252,0.00008383948,0.00001207963],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"not_applicable","study_design_scores_codex":[0.000165669,0.0005030928,0.0358814,0.0003640784,0.0003337878,0.0006345272,0.0000540107,0.0000187846,0.1067238,0.6520916,0.1933975,0.009831719],"study_design_scores_gemma":[0.0001253255,0.000006819346,0.001031854,0.00001093476,0.00003497559,0.00007057854,0.00005018652,0.00006976879,0.06378497,0.00007668661,0.9345864,0.0001515032],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.8432799,0.0001692948,0.0001959416,0.00562266,0.001914369,0.0003019311,0.000007151742,0.0002083485,0.1483004],"genre_scores_gemma":[0.9958677,0.000004508579,0.0001579407,0.001851803,0.0002697191,0.000007873755,0.00002349545,0.00001501749,0.001801976],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.7411889,"threshold_uncertainty_score":0.9373944,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2029144942","doi":"10.1089/blr.2013.9911","title":"The Pharmaceutical/Biopharmaceutical Landscape—Traversing Canada's Patent and Regulatory Regimes","year":2013,"lang":"en","type":"article","venue":"Biotechnology Law Report","topic":"Intellectual Property and Patents","field":"Business, Management and Accounting","cited_by":0,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"","funders":"","keywords":"Biopharmaceutical; Traverse; Patent law; Download; Intellectual property; Political science; Law; Biotechnology; Biology; Geography; Computer science; Cartography","authors":[{"name":"By Daphne Lainson","is_ca":false},{"name":"Nancy Pei","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.07683336325037865,"gpt":0.2268990146442865,"spread":0.1500656513939078,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003089808,0.0001799805,0.0001671689,0.00005762329,0.0006416081,0.0001746932,0.0002384739,0.0002193676,0.000211572],"category_scores_gemma":[0.0001257916,0.0001169228,0.00003955135,0.0001747013,0.0004918591,0.0002262521,0.0002517751,0.0003545944,0.0001240361],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00004003833,"about_ca_system_score_gemma":0.00006084018,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.09613371,"about_ca_topic_score_gemma":0.01477276,"domain_scores_codex":[0.9986751,0.00001222794,0.0003123417,0.0003347767,0.0002272705,0.000438275],"domain_scores_gemma":[0.9993294,0.0000531301,0.0001327627,0.000340058,0.0001158862,0.00002875241],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0002971851,0.0002180761,0.02188828,0.0003818138,0.0006894601,0.002623301,0.00005364117,0.00001248802,0.021622,0.5755642,0.2680411,0.1086085],"study_design_scores_gemma":[0.0003188987,0.000009095065,0.001935538,0.00002243269,0.00006341239,0.0003362206,0.0001241026,0.002347467,0.008278255,0.001742057,0.9845785,0.0002440428],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.8757621,0.00172013,0.00005224552,0.0490342,0.00146684,0.0007448746,0.000001516756,0.0004524231,0.0707657],"genre_scores_gemma":[0.994905,0.00008003325,0.00003058948,0.003503725,0.0002279554,0.00002049125,0.000007463533,0.00001985911,0.001204863],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.7165374,"threshold_uncertainty_score":0.9098852,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4249687475","doi":"10.1089/blr.2007.9911","title":"PTO Agrees to Review Patents on Anti-HIV Drug; Canadian Decision May or May Not Have Profound Implications; PTO Strives to Get a Handle on <i>Markush</i> Claim; CAFC Agrees Patent Law Preempts D.C. Price-Control Measure","year":2007,"lang":"en","type":"article","venue":"Biotechnology Law Report","topic":"Pharmaceutical Economics and Policy","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"","funders":"","keywords":"Human immunodeficiency virus (HIV); Patent law; Law; Control (management); Political science; Law and economics; Business; Economics; Medicine; Virology; Intellectual property; Management","authors":[],"retraction":null,"screen_n_in":null,"score":{"opus":0.084812807088495,"gpt":0.3132504497636691,"spread":0.2284376426751741,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.001966374,0.0005426423,0.001126686,0.0007055955,0.0004328008,0.000122817,0.0008403908,0.0006497437,0.0001751431],"category_scores_gemma":[0.0004941763,0.0005141012,0.0002472002,0.0005612403,0.0002040087,0.0001585117,0.0001843366,0.0005652613,0.001378649],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0007995694,"about_ca_system_score_gemma":0.0002065399,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.01756585,"about_ca_topic_score_gemma":0.09828815,"domain_scores_codex":[0.9953243,0.00003233877,0.001827126,0.001447118,0.0001432802,0.001225843],"domain_scores_gemma":[0.996487,0.0001636997,0.0006983765,0.001617035,0.0001448163,0.000889044],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"not_applicable","study_design_scores_codex":[0.001022827,0.001013644,0.06788173,0.0003588017,0.0006352305,0.0008852368,0.000199068,0.000196011,0.0008390351,0.8398429,0.06077554,0.02635],"study_design_scores_gemma":[0.001018273,0.0003242052,0.02869462,0.0004630279,0.00004179439,0.0001612344,0.00001362901,0.00002606398,0.004718727,0.002826696,0.9609298,0.0007819522],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.6139976,0.004373537,0.002061541,0.268338,0.001775996,0.009937884,0.003494408,0.000509016,0.09551201],"genre_scores_gemma":[0.9628071,0.001417143,0.0008680296,0.03283168,0.0001499118,0.000272544,0.00007191224,0.00007595748,0.001505767],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.9001542,"threshold_uncertainty_score":0.9997311,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4246441873","doi":"10.1089/blr.2009.9923","title":"FDA Cannot Write Definitions on Its Own; APHIS Releases Biotechnology Quality Management System; Environmental Impact Statement Needed for Alfalfa; EU Finds Monsanto Corn Safe; High-Oleic Soybeans Okayed; Farmer Irritated with Biotechnology Opponents; Canada Drops Canola Complaint Against WTO; Cambridge to Ban Level 4 Laboratories; Restriction on Use of Antibiotics in Animal Field; Eight-Feature Corn Gets U.S., Canadian Approval","year":2009,"lang":"en","type":"article","venue":"Biotechnology Law Report","topic":"Genetically Modified Organisms Research","field":"Agricultural and Biological Sciences","cited_by":0,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"","funders":"","keywords":"Aphis; Canola; Agricultural science; Biotechnology; Business; Biology; Agronomy","authors":[],"retraction":null,"screen_n_in":null,"score":{"opus":0.0538544858823115,"gpt":0.2573817806383774,"spread":0.2035272947560658,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0003735166,0.0006229394,0.0008069804,0.0004910328,0.0005487212,0.00006401691,0.0006595194,0.001350506,0.00001312902],"category_scores_gemma":[0.0002555154,0.0003823068,0.00009469572,0.001681897,0.0003784751,0.00008482609,0.0001797753,0.0008527564,0.00000717899],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.002136385,"about_ca_system_score_gemma":0.0004830652,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.744323,"about_ca_topic_score_gemma":0.8546734,"domain_scores_codex":[0.9954755,0.0001830633,0.001076383,0.001277329,0.0006551784,0.001332517],"domain_scores_gemma":[0.9980482,0.0001629057,0.0004689175,0.000668012,0.0002322358,0.0004196588],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.001868376,0.001136055,0.004913107,0.00009769243,0.0003999893,0.003835285,0.00003562228,0.0003079165,0.9094315,0.06820118,0.003454439,0.0063189],"study_design_scores_gemma":[0.001620304,0.009029536,0.3078043,0.0002534366,0.0001062194,0.0002849184,0.001704995,0.0002367117,0.6583735,0.00004305095,0.01927511,0.001267929],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9647344,0.00003831802,0.00008628117,0.02527392,0.0001669189,0.00231179,0.007127324,0.0001569768,0.0001040626],"genre_scores_gemma":[0.9956717,0.0002061646,0.001515521,0.0007718254,0.00002845208,0.00004649027,0.001685063,0.00001652065,0.00005825159],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.3028912,"threshold_uncertainty_score":0.9999459,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4214559639","doi":"10.1089/blr.2008.9935","title":"Third Circuit Accepts Preemption Arguments; More Cautions About Follow-On Biologics; Health Canada Issues Approval Guidance; FDA Takes First Steps in Expanding Drug Safety; Congress Proposes Requiring “Country of Origin” Statement; Congress Wants Direct Treatment Comparisons; Further Congressional Questions About Drug Advertising; Promised Studies Not Done; Warning over Avandia; Inspections of Foreign Facilities Will Not Be Easy; FDA Guidance on Genomics Term Definitions; European Scientists Want More Nanotechnology Regulation; Geron Stem Cell Trial on Hold; South Korea Clarifies Cloning Regulations; Decisions Needed on Antivirals in Advance of Flu Epidemic; Efforts to Control Genetic Testing; Bush Signs Genetic Information Nondiscrimination Act; Drug Companies Petition for Looser Restrictions on Literature on Off-Label Uses; Merck Said to Have Violated Publishing Ethics; Trade in Biotechnology Requires Closer Control; U.N. Alleges Chinese Dissidents Being Used as Organ Sources; Recent Approvals; Approval Delays?; NIH's Open Access Policy Still Has Publishers Roiled; Tilting at the FDA","year":2008,"lang":"en","type":"article","venue":"Biotechnology Law Report","topic":"Intellectual Property and Patents","field":"Business, Management and Accounting","cited_by":0,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"","funders":"","keywords":"Preemption; Drug control; Federal preemption; Law; Medicine; Political science; Statute; Computer science","authors":[],"retraction":null,"screen_n_in":null,"score":{"opus":0.1494701298097443,"gpt":0.3359656712391812,"spread":0.1864955414294369,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","sts"],"consensus_categories":[],"category_scores_codex":[0.002160005,0.0007151972,0.001244014,0.002243506,0.0017143,0.0005617957,0.0008753585,0.00047412,0.000003444474],"category_scores_gemma":[0.005569765,0.0005617856,0.0001255348,0.001788842,0.0007796092,0.002077554,0.0003144665,0.0008743641,0.000001207106],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001791568,"about_ca_system_score_gemma":0.0006148499,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.02531702,"about_ca_topic_score_gemma":0.06038737,"domain_scores_codex":[0.9939342,0.0005643205,0.002721004,0.001134373,0.0008770418,0.0007691094],"domain_scores_gemma":[0.9939482,0.001574708,0.002915618,0.0008064661,0.0006857423,0.00006927292],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"simulation_or_modeling","study_design_gemma":"observational","study_design_scores_codex":[0.0331777,0.003303585,0.1397707,0.001315073,0.0009131079,0.0001527258,0.04464813,0.7273267,0.03103302,0.01218319,0.001163125,0.005012934],"study_design_scores_gemma":[0.08834427,0.007324881,0.6095469,0.04266088,0.000694181,0.0001398622,0.04746789,0.03931388,0.1484884,0.002528713,0.008673376,0.004816811],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9827679,0.0002259023,0.000420039,0.008610766,0.0004778627,0.006506533,0.0006837379,0.0001595368,0.0001477216],"genre_scores_gemma":[0.9970701,0.0002275747,0.0005929452,0.0005222855,0.00006839965,0.0006676637,0.0006771764,0.00006546127,0.0001084009],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.6880128,"threshold_uncertainty_score":0.9996834,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W3172086909","doi":"10.1089/blr.2021.29236.mg","title":"The EPO Guidelines They Are a-Changin’","year":2021,"lang":"en","type":"article","venue":"Biotechnology Law Report","topic":"Intellectual Property and Patents","field":"Business, Management and Accounting","cited_by":0,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Quest University Canada","funders":"","keywords":"European patent office; German; Convention; Law; Patent application; Political science; Medicine; Business; Library science; Computer science; History","authors":[{"name":"Benjamin Quest","is_ca":false},{"name":"DR. Markus Grammel","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.1541552739653997,"gpt":0.2621810474744923,"spread":0.1080257735090927,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004463312,0.0001513805,0.0001694617,0.00006172603,0.000598742,0.0001610855,0.00030833,0.0002924165,0.0001339874],"category_scores_gemma":[0.001163574,0.00009464258,0.00009433683,0.0002957933,0.0001744421,0.0001700052,0.0003673209,0.0002313839,0.0006735573],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00001529046,"about_ca_system_score_gemma":0.0000275656,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0006303641,"about_ca_topic_score_gemma":0.001683724,"domain_scores_codex":[0.9987715,0.000008253595,0.0003937836,0.0003288306,0.0001775493,0.0003200974],"domain_scores_gemma":[0.998584,0.00002911176,0.0002581201,0.0006382774,0.0004841115,0.000006424633],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00005605159,0.0001278413,0.003717851,0.00008808008,0.0002168776,0.006681588,0.00002561455,0.00001856584,0.008780237,0.8136799,0.1479076,0.01869974],"study_design_scores_gemma":[0.00009681023,0.000004177731,0.0001458292,0.00002975361,0.00002380106,0.0004576772,0.0001460838,0.0001884888,0.01050986,0.0117103,0.9765386,0.0001486265],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"other","genre_gemma":"empirical","genre_scores_codex":[0.2462141,0.00358617,0.001042356,0.3002159,0.007116028,0.0007510719,0.00000560262,0.002288771,0.43878],"genre_scores_gemma":[0.9812546,0.0001178218,0.0001667268,0.006097559,0.0009387704,0.0000244717,0.00002748873,0.00002976349,0.01134274],"genre_candidate":"empirical","genre_consensus":null,"teacher_disagreement_score":0.828631,"threshold_uncertainty_score":0.8657441,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2031108337","doi":"10.1089/blr.2012.9750","title":"Securities Fraud Class Action Lawsuits Against Life Science Companies on the Rise in the First Quarter 2012","year":2012,"lang":"en","type":"article","venue":"Biotechnology Law Report","topic":"Legal Education and Practice Innovations","field":"Social Sciences","cited_by":0,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"","funders":"","keywords":"Class action; Quarter (Canadian coin); Action (physics); Class (philosophy); Business; Law; Securities fraud; Political science; History; State (computer science); Computer science; Supreme court","authors":[{"name":"By David Kotler","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.06849701425227893,"gpt":0.367051030329021,"spread":0.2985540160767421,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["sts"],"consensus_categories":[],"category_scores_codex":[0.003498988,0.00009488413,0.00009750518,0.000149386,0.001854176,0.0001977567,0.0005240069,0.0002398397,0.00009627981],"category_scores_gemma":[0.001528217,0.00006043227,0.00003195691,0.001203834,0.002400992,0.001102598,0.00004258315,0.0006955424,0.0001161147],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001261745,"about_ca_system_score_gemma":0.0004254739,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002354366,"about_ca_topic_score_gemma":0.008402922,"domain_scores_codex":[0.9985613,0.0001500234,0.000277175,0.0001877198,0.0004329315,0.0003909071],"domain_scores_gemma":[0.9987512,0.0003642793,0.0002382002,0.0004739334,0.0001237619,0.00004868566],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"not_applicable","study_design_scores_codex":[0.000003617274,0.0001392422,0.002975779,0.000002376469,0.000005527715,0.000003763757,0.009895048,0.000001042852,0.00008026447,0.9663404,0.02024241,0.0003104946],"study_design_scores_gemma":[0.00004362398,0.00001483848,0.01178855,0.000008816489,0.000005255694,0.00001884231,0.0269321,0.000005909098,0.0004778958,0.001093247,0.9595258,0.00008512041],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.4421137,0.0001629212,0.00001082363,0.4059305,0.001202491,0.0002919268,0.000001989073,0.0001250406,0.1501606],"genre_scores_gemma":[0.9930075,0.00007139708,0.00003412724,0.006238676,0.000292043,0.00006791188,0.000002101982,0.000005067011,0.0002811132],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.9652472,"threshold_uncertainty_score":0.9994453,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2039505100","doi":"10.1089/blr.2011.9983","title":"Expansion of the Canadian Research Exemption for Biotechnology Research Tools","year":2011,"lang":"en","type":"article","venue":"Biotechnology Law Report","topic":"Intellectual Property and Patents","field":"Business, Management and Accounting","cited_by":0,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"","funders":"","keywords":"Download; Library science; Experimental biology; Political science; Sociology; Law; Biology; Computer science; World Wide Web; Computational biology","authors":[{"name":"Rebecca Goulding","is_ca":false},{"name":"Matthew R. Voell","is_ca":false},{"name":"Emily Marden","is_ca":false},{"name":"Ed Levy","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.5336590373403922,"gpt":0.3447900543510486,"spread":0.1888689829893436,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003616047,0.0001339921,0.0002069696,0.0009610624,0.001199098,0.00006118976,0.0008987797,0.001085294,0.0001497505],"category_scores_gemma":[0.002081314,0.00009413102,0.0000921398,0.001412817,0.001629143,0.0002798701,0.0005098306,0.0008865558,0.0001810682],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001332765,"about_ca_system_score_gemma":0.0002465521,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.2715958,"about_ca_topic_score_gemma":0.2066686,"domain_scores_codex":[0.9978811,0.00004880807,0.0004283221,0.000463094,0.0004209917,0.0007576674],"domain_scores_gemma":[0.9978052,0.00007692627,0.0001676951,0.0009904605,0.000941913,0.00001783831],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0001127338,0.00008326424,0.001283331,0.0001087633,0.00003562086,0.00008814826,0.00008291715,5.512591e-7,0.03372835,0.9481588,0.008155821,0.008161717],"study_design_scores_gemma":[0.0002530209,0.0001058687,0.001235802,0.00008620224,0.00001630452,0.00008372095,0.0002969992,0.0001250587,0.3604146,0.05052101,0.5866793,0.0001822003],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.8123588,0.0001342953,0.0002463786,0.0172019,0.001281372,0.002566052,0.00001034949,0.0003379784,0.1658629],"genre_scores_gemma":[0.9980513,0.00001519402,0.0003066983,0.0002978585,0.0001570836,0.0001195038,0.00001662856,0.00002745997,0.001008267],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.8976378,"threshold_uncertainty_score":0.9222613,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4234058516","doi":"10.1089/blr.2010.9960","title":"In the High Court of Justice Before The Hon. Mr. Justice Arnold: <i>Intervet UK Ltd. v. Merial, the Queen's University of Belfast, and the University of Saskatchewan</i> (Case no. HC09C00779)","year":2010,"lang":"en","type":"article","venue":"Biotechnology Law Report","topic":"Conflict of Laws and Jurisdiction","field":"Social Sciences","cited_by":0,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"","funders":"","keywords":"Queen (butterfly); Economic Justice; Law; Sociology; Biology; Political science; Botany","authors":[],"retraction":null,"screen_n_in":null,"score":{"opus":0.006586631673614615,"gpt":0.2323855653623284,"spread":0.2257989336887137,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["sts"],"consensus_categories":[],"category_scores_codex":[0.002477257,0.0001190709,0.0002778974,0.00004506786,0.0008897327,0.00001292256,0.000761377,0.0003941946,0.00006767972],"category_scores_gemma":[0.0002551099,0.00006808392,0.0001120224,0.0003523541,0.006376892,0.00009456935,0.0002417911,0.0005464539,0.00000205318],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00002549094,"about_ca_system_score_gemma":0.0001678432,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.1357001,"about_ca_topic_score_gemma":0.1363426,"domain_scores_codex":[0.9986989,0.0002950196,0.0002847311,0.0002293681,0.0002842862,0.0002076676],"domain_scores_gemma":[0.9981003,0.0003530569,0.0005790485,0.0007074829,0.0002311739,0.00002894188],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0007074979,0.0003581513,0.001757058,0.0001564371,0.0003111971,0.001703011,0.07706686,0.00001025707,0.00663702,0.9003228,0.008818849,0.002150859],"study_design_scores_gemma":[0.001617869,0.0002217052,0.002815659,0.00004645933,0.001291524,0.0006355952,0.2426506,0.00004066495,0.002475244,0.003037147,0.7449728,0.0001947601],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9238715,0.0000548889,0.0001338714,0.06915093,0.0006549135,0.0005256382,0.00004281318,0.00003750607,0.005527892],"genre_scores_gemma":[0.9984357,0.0002025876,0.0001348692,0.0001446114,0.00009709813,6.353436e-7,0.000002233498,0.000005255102,0.0009770157],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.8972856,"threshold_uncertainty_score":0.9963272,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4234700261","doi":"10.1089/blr.2012.9649","title":"Canada Cancels Pfizer's Viagra Patent","year":2012,"lang":"en","type":"article","venue":"Biotechnology Law Report","topic":"Biotechnology and Related Fields","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"","funders":"","keywords":"Patent law; Download; Volume (thermodynamics); Political science; Business; Law; Intellectual property; Computer science; World Wide Web; Physics","authors":[],"retraction":null,"screen_n_in":null,"score":{"opus":0.01869433833570806,"gpt":0.2323175447619683,"spread":0.2136232064262603,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["research_integrity"],"consensus_categories":["research_integrity"],"category_scores_codex":[0.0002062503,0.0002089033,0.0003808504,0.00009243806,0.0001524589,0.00000312523,0.0001456783,0.005460321,0.0001691904],"category_scores_gemma":[0.00007414861,0.0001670207,0.00008209332,0.0002579817,0.0004552933,0.00004784933,0.0001039054,0.002470897,0.00005133676],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00022048,"about_ca_system_score_gemma":0.0005426115,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.2621607,"about_ca_topic_score_gemma":0.09764691,"domain_scores_codex":[0.9984073,0.00001390561,0.0004073115,0.0003285314,0.0002022991,0.0006406461],"domain_scores_gemma":[0.9987705,0.00001659257,0.0001627007,0.0008139474,0.00005923166,0.0001769818],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0002152318,0.0009032548,0.06570999,0.0001673278,0.001167974,0.01977279,0.00006496572,0.000002975007,0.195257,0.5997126,0.101669,0.01535685],"study_design_scores_gemma":[0.0003400779,0.0000687227,0.003756062,0.00002720865,0.00009355204,0.01072125,0.00002911566,0.000002461134,0.3212846,0.000100723,0.6634111,0.0001650934],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.7513153,0.00843861,0.0005423274,0.1992618,0.003427596,0.0007467691,0.00001780236,0.0014663,0.0347835],"genre_scores_gemma":[0.993192,0.0003244487,0.0007079676,0.003567604,0.0001349816,0.00002853591,0.00002808901,0.00002476163,0.001991616],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.5996119,"threshold_uncertainty_score":0.9998304,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4239469862","doi":"10.1089/blr.2011.9992","title":"A Close Look at Non-Inferiority Trials; FDA Issues Guidance on Safety for Clinical Trials; Geron Human Embryonic Stem Cell Trial Starts; National Academy of Sciences Discusses Postmarketing Trials; Bone Marrow Stem Cell Trial Authorized in Israel; Canadian Company Asked to Submit Proposal on Brain Injury Treatment to DoD","year":2011,"lang":"en","type":"article","venue":"Biotechnology Law Report","topic":"Biomedical Ethics and Regulation","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"","funders":"","keywords":"Clinical trial; Stem cell; Medicine; Embryonic stem cell; Internal medicine; Biology","authors":[],"retraction":null,"screen_n_in":null,"score":{"opus":0.217967746319671,"gpt":0.4613964784922311,"spread":0.2434287321725601,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaresearch","metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.08068304,0.0006512462,0.004412223,0.001132152,0.000553639,0.00004752467,0.0004565203,0.002664047,0.00005799998],"category_scores_gemma":[0.008342667,0.0004463349,0.001008749,0.0008400177,0.001372621,0.00009361912,0.0001658464,0.0009808476,0.00001473367],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00155913,"about_ca_system_score_gemma":0.003057842,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.005572882,"about_ca_topic_score_gemma":0.007548964,"domain_scores_codex":[0.9850059,0.004049838,0.006957693,0.0016985,0.001353223,0.0009348949],"domain_scores_gemma":[0.9904923,0.004726549,0.003175028,0.0005853667,0.0003095081,0.0007112579],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.8257329,0.005134602,0.00106267,0.0003877586,0.0005323692,0.000242012,0.0006535259,0.000006107569,0.09587318,0.04306218,0.004675634,0.02263705],"study_design_scores_gemma":[0.4454995,0.07859003,0.005101952,0.001336723,0.001034475,0.0000815811,0.0005907142,0.0001811505,0.3518455,0.003899619,0.1102236,0.001615146],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9195217,0.0001625333,0.00005355701,0.06088445,0.001561868,0.01614877,0.0004351104,0.00013912,0.001092913],"genre_scores_gemma":[0.9926332,0.00009078303,0.002521525,0.0008809087,0.001251856,0.0006868372,0.000115915,0.00006215347,0.001756843],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.3802333,"threshold_uncertainty_score":0.9997988,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4252964882","doi":"10.1089/blr.2006.25.389","title":"First Product from Transgenic Animal Cleared in Europe; Mab Associated with Brain Infection Allowed Back on Market; Should U.S. Approve Follow-On Biologics?; D.C. Court of Appeals Finds Constitutional Right to Unapproved Drugs; Participating in Efforts Against Counterfeiters; Specifications Issued for Veterinary Biologics and Biotechnology Products; Electronic Communications Are Desirable for Important Drug Information; Guidance for Antiviral Drug Development; Short Stories: New Indication for Remicade; Bone Stimulant Approved in Canada","year":2006,"lang":"en","type":"article","venue":"Biotechnology Law Report","topic":"Intellectual Property and Patents","field":"Business, Management and Accounting","cited_by":0,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"","funders":"","keywords":"Clearance; Product (mathematics); Supreme court; Medicine; Food and drug administration; Law; Political science; Pharmacology","authors":[],"retraction":null,"screen_n_in":null,"score":{"opus":0.0803028059876358,"gpt":0.2432839347296266,"spread":0.1629811287419908,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.001331451,0.0003324698,0.0005604976,0.000453349,0.0002934066,0.00004469182,0.0003235835,0.0003111595,0.000002389187],"category_scores_gemma":[0.001347446,0.0002960385,0.00004660674,0.0008888572,0.0002933661,0.000309284,0.00008353218,0.0002981845,5.415686e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005660207,"about_ca_system_score_gemma":0.0006160145,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.01888967,"about_ca_topic_score_gemma":0.2179511,"domain_scores_codex":[0.9972606,0.0000394823,0.001319276,0.0006674213,0.0001518378,0.0005614064],"domain_scores_gemma":[0.9979452,0.0003404561,0.0008763847,0.0004682194,0.0003520571,0.00001763148],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0556182,0.007583232,0.3658703,0.005908723,0.001793993,0.00008300597,0.003196505,0.01001938,0.3319185,0.1658359,0.0391229,0.01304933],"study_design_scores_gemma":[0.02145621,0.003326911,0.06056757,0.003659903,0.0003261319,0.00003069938,0.001429695,0.09818447,0.2723038,0.005873271,0.528994,0.003847398],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9810459,0.00008298546,0.004894502,0.007133791,0.0001032135,0.006278312,0.0002601386,0.00009466443,0.0001064923],"genre_scores_gemma":[0.9907715,0.00002572226,0.004404964,0.0003159665,0.000043801,0.001880492,0.002491334,0.00002743876,0.00003876485],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.4898711,"threshold_uncertainty_score":0.9999492,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null}]}